Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

5.6K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating natural killer cells are phenotypically and functionally altered in age-related macular degeneration.

Cell reports. Medicine·2026
Same author

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth.

Clinical pharmacology and therapeutics·2026
Same author

Reframing livestock antimicrobial use as a global public good.

One health (Amsterdam, Netherlands)·2026
Same author

Endothelial IL-36 receptor activation promotes vascular stability to limit pathological microvessel permeability in the CNS.

Cell reports·2025
Same author

Breaking Bruch's: How changes in Bruch's membrane influence retinal homeostasis.

Experimental eye research·2025
Same author

A Role for SARM1 in Photoreceptor Cell Death.

Advances in experimental medicine and biology·2025

Related Experiment Video

Updated: May 28, 2025

Transpupillary Two-Photon In Vivo Imaging of the Mouse Retina
09:03

Transpupillary Two-Photon In Vivo Imaging of the Mouse Retina

Published on: February 13, 2021

4.2K

Current Perspectives of TLR2 Signalling in the Retina.

Rachel Dalton1,2, Sarah Doyle3,4

  • 1Trinity College Institute of Neuroscience, Trinity College, Dublin, Ireland.

Advances in Experimental Medicine and Biology
|February 10, 2025
PubMed
Summary

Toll-like receptor 2 (TLR2) activation drives inflammation in retinal diseases like AMD and DR. Inhibiting TLR2 may offer a new therapeutic strategy for these conditions.

Keywords:
AMDCNVChronic inflammationDAMPsDiabetic retinopathyInnate immune responseMyD88RPERetinaTLR2

More Related Videos

A TIRF Microscopy Technique for Real-time, Simultaneous Imaging of the TCR and its Associated Signaling Proteins
16:10

A TIRF Microscopy Technique for Real-time, Simultaneous Imaging of the TCR and its Associated Signaling Proteins

Published on: March 22, 2012

23.8K
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.3K

Related Experiment Videos

Last Updated: May 28, 2025

Transpupillary Two-Photon In Vivo Imaging of the Mouse Retina
09:03

Transpupillary Two-Photon In Vivo Imaging of the Mouse Retina

Published on: February 13, 2021

4.2K
A TIRF Microscopy Technique for Real-time, Simultaneous Imaging of the TCR and its Associated Signaling Proteins
16:10

A TIRF Microscopy Technique for Real-time, Simultaneous Imaging of the TCR and its Associated Signaling Proteins

Published on: March 22, 2012

23.8K
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.3K

Area of Science:

  • Immunology
  • Ophthalmology
  • Molecular Biology

Background:

  • Toll-like receptor 2 (TLR2) signaling initiates innate immunity, recognizing danger signals to protect against pathogens.
  • Dysregulated TLR2 activation, triggered by endogenous ligands in degenerating retinas, contributes to chronic inflammation.
  • This aberrant activation leads to excessive pro-inflammatory cytokine production, exacerbating retinal damage.

Purpose of the Study:

  • To review the role of TLR2 in retinal diseases, specifically age-related macular degeneration (AMD) and diabetic retinopathy (DR).
  • To investigate the potential of TLR2 inhibition as a therapeutic approach for retinal disorders.

Main Methods:

  • Literature review of studies investigating TLR2 signaling in retinal pathophysiology.
  • Analysis of evidence linking TLR2 activation to AMD and DR pathogenesis.
  • Exploration of preclinical and clinical data on TLR2 inhibitors in retinal disease models.

Main Results:

  • Evidence suggests TLR2 plays a significant role in the inflammatory processes underlying AMD and DR.
  • Aberrant TLR2 activation by sterile endogenous ligands is a key driver of chronic retinal inflammation.
  • Preclinical studies indicate that TLR2 inhibition can mitigate inflammatory responses in the retina.

Conclusions:

  • TLR2 dysregulation is implicated in the pathogenesis of major retinal diseases.
  • Targeting TLR2 offers a promising therapeutic avenue for managing chronic inflammation in AMD and DR.
  • Further research into TLR2 inhibition is warranted to develop effective treatments for these debilitating conditions.